PATENT CLAIM ANALYSIS

Application Number: 16038102
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "472000"]

Abstract:
Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.

Claim (Index 23):
The method of  claim 1 , wherein the antiemetic is aprepitant, dronabinol, perphenazine, palonosetron, trimethyobenzamide, metoclopromide, domperidone, prochlorperazine, promethazine, chlorpromazine, trimethobenzamide, ondansetron, granisetron, hydroxyzine, acetylleucine monoethanolamine, alizapride, azasetron, benzquinamide, bietanautine, bromopride, buclizine, clebopride, cyclizine, dimenhydrinate, diphenidol, dolasetron, meclizine, methallatal, metopimazine, nabilone, oxyperndyl, pipamazine, scopolamine, sulpiride, tetrahydrocannabinol, thiethylperazine, thioproperazine, tropisetron, droperidol, haloperidol, prochloperazine, metoclopramide, diphenhydramine, cannabis, midazolam, lorazepam, hyoscine, dexamethasone, emetrol, propofol, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 95.0
- Lexical Diversity: 1.07407
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14789886', '14789888', '15263243', '14789883', '14036946']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7664476683216117
- 35 USC 102 Novelty (BERT): 0.5611115789705902
- Combined Prediction Score: 0.7459140593865096
- Mean Citation Score: 414.545522
- Max Citation Score: 431.87375
- Similarity Product: 403.0530030576885

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test